Search research articles
Contact Us
Filters
Showing results (141-150 of 185) with videos related to
Page
of 19
Sort By:
Cancer Research
|
November 24, 2001
A genetically engineered influenza A virus with ras-dependent oncolytic properties
M Bergmann, I Romirer, M Sachet, et al.
British Journal of Cancer
|
July 1, 1995
Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer
M Fiegl, C Tueni, T Schenk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2009
HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer
S F Schoppmann, D Tamandl, L Roberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1993
Aneuploidy fraction but not DNA index is important for the prognosis of patients with stage I and II breast cancer--10-year results
M F Gnant, G H Blijham, A Reiner, et al.
Biochemical Pharmacology
|
January 7, 1998
Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro
R M Mader, A E Sieder, J Braun, et al.
Geburtshilfe Und Frauenheilkunde
|
January 1, 1996
[Plasminogen activator inhibitor 1 and prognosis in breast carcinoma]
K Mayerhofer, J Stolzlechner, S Yildiz, et al.
European Journal of Cancer & Clinical Oncology
|
July 1, 1988
Escalating dose regimen of intraperitoneal mitoxantrone: phase I study--clinical and pharmacokinetic evaluation
B Blöchl-Daum, H G Eichler, H Rainer, et al.
Onkologie
|
February 1, 1987
Phase-I study of intraperitoneal mitoxantrone--clinical and pharmacokinetic evaluation
B Blöchl-Daum, H G Eichler, H Rainer, et al.
Anticancer Research
|
February 24, 2001
Different transendothelial migration behaviour pattern of blood monocytes derived from patients with benign and malignant diseases of the breast
B Gebhard, M Gnant, G Schütz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer
P Birner, G Oberhuber, J Stani, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 185) with videos related to
Sort By:
Page
of 19
Cancer Research
|
November 24, 2001
A genetically engineered influenza A virus with ras-dependent oncolytic properties
M Bergmann, I Romirer, M Sachet, et al.
British Journal of Cancer
|
July 1, 1995
Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer
M Fiegl, C Tueni, T Schenk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2009
HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer
S F Schoppmann, D Tamandl, L Roberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1993
Aneuploidy fraction but not DNA index is important for the prognosis of patients with stage I and II breast cancer--10-year results
M F Gnant, G H Blijham, A Reiner, et al.
Biochemical Pharmacology
|
January 7, 1998
Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro
R M Mader, A E Sieder, J Braun, et al.
Geburtshilfe Und Frauenheilkunde
|
January 1, 1996
[Plasminogen activator inhibitor 1 and prognosis in breast carcinoma]
K Mayerhofer, J Stolzlechner, S Yildiz, et al.
European Journal of Cancer & Clinical Oncology
|
July 1, 1988
Escalating dose regimen of intraperitoneal mitoxantrone: phase I study--clinical and pharmacokinetic evaluation
B Blöchl-Daum, H G Eichler, H Rainer, et al.
Onkologie
|
February 1, 1987
Phase-I study of intraperitoneal mitoxantrone--clinical and pharmacokinetic evaluation
B Blöchl-Daum, H G Eichler, H Rainer, et al.
Anticancer Research
|
February 24, 2001
Different transendothelial migration behaviour pattern of blood monocytes derived from patients with benign and malignant diseases of the breast
B Gebhard, M Gnant, G Schütz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer
P Birner, G Oberhuber, J Stani, et al.
Page
of 19